Human IL-9 ELISA Kit Antibodies (G-L) Jul 2008] Swissprot No O60216

Jul 2008] Swissprot No O60216 Gene Accession 5885 WB Predicted band size 72 kDa WB Positive control WB Recommended dilution 500-2000 IHC predicted cell location Predicted cell location: Nucleus IHC positive control Positive control: Human lung cancer IHC Recommed dilution Recommended dilution: 50-100 Storage

40 cycles of Denaturation 95 b0C 00:15 and Annealing/Extension 63 b0C 00:40 (fluorescence read during 63 b0C step) Internal control acceptance criteria (IPC) Mean Ct(IPC) of sample should be within b10

Experiments requiring a 12% native gel

This isozyme has a high preference for lipid hydroperoxides and protects cells against membrane lipid peroxidation and cell death

Immunohistochemical analysis of paraffin-embedded Human ovarian cancer and Human tonsil tissue using P113849(VIM Antibody) at dilution 1/150

Human IL-9 ELISA Kit Antibodies (G-L) Jul 2008] Swissprot No O60216Specifications Name Human IL 9 ELISA Kit Hgnc ID 6029 Specie human Assay Type sandwich Assay Time 3. 5 h Sample Type Serum, plasma, cell culture supernatant, and other biological samples Sample Amount 100 L Sensitivity 0. 06 pg mL Range Standard 7. 81 pg mL 500 pg mL Recovery 80% 117% Average Recovery 104% Intra Precision 2. 9% 3. 1% Inter Precision 3. 3% 5. 7% Plate Type Detachable 96 well plate Platform ELISA Components 96 well polystyrene enzyme